CONSENT AND EXCHANGE AGREEMENTConsent and Exchange Agreement • September 16th, 2014 • CorMedix Inc. • Pharmaceutical preparations • New York
This Consent and Exchange Agreement (the “Agreement”) is made as of this 15 day of September 2014, by and among CorMedix Inc., a Delaware corporation (the “Company”), and the undersigned holders (the “Holders”) of all of the outstanding warrants to purchase common stock, $0.001 par value, of the Company (the “Common Stock”) issued by the Company on March 10, 2014 (the “March 2014 Warrants”).
CONSENT AND EXCHANGE AGREEMENTConsent and Exchange Agreement • September 16th, 2014 • CorMedix Inc. • Pharmaceutical preparations • New York
This Consent and Exchange Agreement (the “Agreement”) is made as of this 15 day of September 2014, by and among CorMedix Inc., a Delaware corporation (the “Company”), and the undersigned holders (the “Holders”) of (i) all of the outstanding shares (the “Existing Series C-2 Stock”) of the Company’s non-voting convertible Series C-2 preferred stock (the “Series C-2 Preferred Stock”), (ii) all of the outstanding shares (the “Existing Series D Stock”) of the Company’s non-voting convertible Series D preferred stock (the “Series D Preferred Stock”), (iii) all of the outstanding shares (the “Existing Series E Stock”) of the Company’s non-voting convertible Series E preferred stock (the “Series E Preferred Stock”), (iv) all of the outstanding warrants to purchase common stock, $0.001 par value, of the Company (the “Common Stock”) issued by the Company in May 2013 (the “May 2013 Warrants”), and (v) all of the outstanding warrants to purchase common stock of the Company issued by the Company in
SERIES A-1 PREFERRED CONSENT AND EXCHANGE AGREEMENTConsent and Exchange Agreement • August 11th, 2009 • Glowpoint Inc • Telephone communications (no radiotelephone) • New York
THIS SERIES A-1 PREFERRED CONSENT AND EXCHANGE AGREEMENT (this “Agreement”) is dated as of August 11, 2009, by and among Glowpoint, Inc., a Delaware corporation (the “Company”), and the holders of the Company’s Series A-1 Convertible Preferred Stock set forth on Exhibit A attached hereto (each a “Holder” and collectively the “Holders”).
AMENDMENT, CONSENT AND EXCHANGE AGREEMENTConsent and Exchange Agreement • September 4th, 2014 • Wet Seal Inc • Retail-women's clothing stores
This Amendment, Consent and Exchange Agreement (the “Agreement”), dated as of September 3, 2014, is by and between The Wet Seal, Inc., a Delaware corporation with offices located at 26972 Burbank, Foothill Ranch, CA 92610 (the “Company”), and the holder identified on the signature page hereto (“Holder”).
